June 23, 2015

SEATTLE, June 23, 2015—Eye care practices across the United States are facing more challenges than ever in attracting and retaining a loyal base of high value contact lens patients, especially as consumer healthcare expectations and purchasing habits evolve. Expanding its heritage of partnering with eye care practitioners, CooperVision, Inc. is unveiling CooperVision Advantage™ – an inclusive set of business tools designed to support practice growth.


CooperVision estimates that the typical contact lens patient can provide more than $30,000 in lifetime value to a practice. However, an estimated 21 percent of contact lens wearers drop out each year. CooperVision Advantage aims to add new patients, minimize the non-clinical reasons for patient loss, and ensure that practitioners have access to the most comprehensive portfolio of contact lenses to provide options for every eye.


At launch, CooperVision Advantage brings together a number of tools under a single, unified brand. It incorporates EyeCare Prime which includes WebSystem3®, Premier, and LensFerry® services – all of which have been widely recognized for helping optimize practice profitability through better patient retention and acquisition. CooperVision Advantage also includes the company’s promotional and loyalty programs, training and education initiatives, and other value-added services. Other services are expected to be added over time.


“Being a true partner means more than just providing pricing programs,” said Simon Seshadri, Vice President, North America Marketing for CooperVision. “CooperVision Advantage provides key practice-building services to help eye care practitioners with patient retention, patient acquisition, supply cost and keeping sales within their practice. It’s one more way we’re focused on growing together, creating a stronger marketplace in which we all can thrive.”


For additional information, visit coopervision.com/advantage.




About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.


About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has close to 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.


Media Contact

Heather Kowalzcyk, McDougall Communications

+1-585-434-2148 or heather@mcdougallpr.com